- Bristol Myers Squibb (Princeton, NJ)
- …and in their personal lives. Read more: careers.bms.com/working-with-us . **Position Description: Oncology Clinical Biomarker Lead (Associate/Director), ... mechanism of action, and predictive biomarkers in our late-stage clinical oncology portfolio. Ideal candidates will possess...and experience working in a matrixed industrial environment. The Clinical Biomarker Lead role will… more
- Pfizer (New York, NY)
- …of the development team to establish, lead , coordinate, and execute the early oncology clinical development plan(s). You will lead the development of the ... **POSITION RESPONSIBILITIES** + Partner closely with the Global Development Lead (GDL) in the execution of the clinical...precision medicine, and development operations. + Partner with Translational Oncology and Biomarker teams to ensure … more
- Bristol Myers Squibb (Princeton, NJ)
- … early development portfolio & 2) input to translational medicine plans across the oncology portfolio. The WWM EDAP Lead is a strategic leader within Worldwide ... Medical organization, accountable to the EA Development teams. The Lead will support development plans via interpretation of evolving pre- clinical & clinical … more
- Bristol Myers Squibb (Princeton, NJ)
- …implementation, planning, and execution of assigned clinical trial activities. Serves as Clinical Trial Lead for one or more trials + Successfully leads, ... team members + May support clinical development planning (collaboration with Clinical Development Lead / Clinical Trial Physician for provision and… more
- Bristol Myers Squibb (Princeton, NJ)
- …training Clinical Development Expertise & Strategy + In collaboration with the Clinical Development Lead , designs and develops clinical plans and ... gain their inputs on emerging science in drug and biomarker research, disease knowledge, and design of clinical...is required + Ability to communicate information clearly and lead presentations in scientific and clinical settings… more
- Pfizer (New York, NY)
- …Proof of Concept at which point molecule may be handed to the late-stage Oncology Clinical Development team for post-Proof of Concept (typically phase 3) ... Oncology Regulatory Strategy, Clinical Pharmacology and Precision Medicine, Oncology Clinical Development and Operations, Pharm Sci and Product Teams. +… more
- Bristol Myers Squibb (Princeton, NJ)
- …(TLs) in order to gain their inputs on emerging science in drug and biomarker research, disease knowledge and design of clinical development studies and ... the study in partnership with CSs. **Reporting and Developmental Value:** + Reports to Clinical Development Lead (CDL) + Broad experience in management of and… more